Identification of nuclear and cytoplasmic proteins that interact specifically with an AU-rich, as-acting inhibitory sequence in the 3′ untranslated region of human papillomavirus type 1 late mRNAs

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3659-3667

  Zhao, Cuiping ^a   Tan, Wei ^a   Sokolowski, Marcus ^a   Schwartz, Stefan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CELL PROLIFERATION; COMPETITIVE INHIBITION; CROSS LINKING; EPITHELIUM CELL; GENE EXPRESSION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; VIRUS CAPSID; VIRUS CHARACTERIZATION;

BASE SEQUENCE; BINDING SITES; BINDING, COMPETITIVE; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; PROTO-ONCOGENES; RNA, MESSENGER; RNA, VIRAL;

EID: 0029888088     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bickel, M., Y. Iwai, D. H. Pluznik, and R. B. Cohen. 1992. Binding of sequence-specific proteins to the adenosine- plus uridine-rich sequences of the murine granulocyte/macrophage colony-stimulating factor mRNA. Proc. Natl. Acad. Sci. USA 89:10001-10005.
2. Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. 1991. An inducible cytoplasmic factor (AU-B) hinds selectively to AUUUA multimers in the 3′ untranslated region of lymphokine mRNA. Mol. Cell. Biol. 11:3288-3295.
3. Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. 1992. AU RNA-binding factors differ in their binding specificities and affinities. J. Biol. Chem. 267:6302-6309.
4. Brewer, G. 1991. An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11:2460-2466.
5. Danos, O., M. Katinka, and M. Yaniv. 1982. Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. EMBO J. 1:231-236.
6. de Villiers, E. 1994. Human pathogenic papillomavirus types: an update. Curr. Top. Microbiol. Immunol. 186:1-12.
7. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
8. Eng, A. M., Y.-T. Jin, L. Y. Matsuoka, C. V. Grgurich, J. Robinson, and A. Armin. 1985. Correlative studies of verruca vulgaris by H ′ E, PAP immunostaining, and electron microscopy. J. Cutaneous Pathol. 12:46-54.
9. Furth, P. A., and C. C. Baker. 1991. An element in the bovine papillomavirus late 3′ untranslated region reduces polyadenylated cytoplasmic RNA levels. J. Virol. 65:5806-5812.
10. Furth, P. A., W.-T, Choe, J. H. Rex, J. C. Byrne, and C. C. Baker. 1995. Sequences homologous to 5′ splice sites are required for the inhibitory activity of papillomavirus late 3′ untranslated regions. Mol. Cell. Biol. 14: 5278-5289.
11. Galloway, D. A., and J. K. McDougall. 1989. Human papillomaviruses and carcinomas. Adv. Virus Res. 37:125-170.
12. Geek, P., M. M. Medveczky, C.-S. Chou, A. Brown, J. Cus, and P. G. Medveczky. 1994. Herpesvirus saimiri small RNA and interlcukin-4 mRNA AUUUA repeats compete for sequence-specific factors including a novel 70K protein. J. Gen. Virol. 75:2293-2301.
13. Gillis, P., and J. S. Malter. 1991. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokinc, lymphokine, and oncogene mRNAs. J. Biol. Chem. 266:3172-3177.
14. Graham, F. J., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-460.
15. Grussendorf, E.-L, and H. zur Hausen. 1979. Localization of viral DNAreplication in sections of human warts by nucleic acid hybridization with complementary RNA of human papilloma virus type 1. Arch. Dermatol. Res. 264:55-63.
16. Howley, P. M. 1991. Papillomaviridae and their replication, p. 743-768. In B. N. Fields and D. M. Knipe (ed.), Fundamental virology. Raven Press, New York.
17. Howley, P. M. 1991. Role of the human papillomaviruses in human cancer. Cancer Res. 51:5019-5022.
18. Jenson, A. B., J. D. Rosenthal, C. Olson, F. Pass, W. D. Lancaster, and K. Shah. 1980. Immunologic relatedness of papillomaviruses from different species. JNCI 64:495-500.
19. Jeon, S., and P. F. Lambert. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 tnRNAs: implications for cervical carcinogcncsis. Proc. Natl. Acad. Sci. USA 92:1654-1658.
20. Keller, W. 1995. No end yet to messenger RNA ,V end processing! Cell 81:829-S32.
21. Kennedy, I. M., J. K. Haddow, and J. B. Clements. 1990. Analysis of human papillomavirus type 16 late mRNA 3′ processing signals in vitro and in vivo. J. Virol. 64:1825-1829.
22. Kennedy, I. M., J. K. Haddow, and J. B. Clements. 1991. A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J. Virol. 65:2093-2097.
23. Laimins, L. A. 1993. The biology of human papillomaviruses: from warts to cancer. Infect. Agents Dis. 2:74-86.
24. Lambert, P. F. 1991. Papillomavirus DNA replication. J. Virol. 65:3417-3420.
25. Laurent, R., J. L. Kienzier, O. Croissant, and G. Orth. 1982. Two anatomoclinical types of warts with plantar localization: specific cytopathogcnic effects of papillomavirus. Arch. Dermatol. Res. 274:101-111.
26. Malter, J. S. 1989. Identification of an AUUUA-specific messenger RNA binding protein. Science 246:664-666.
27. Müller, W. E. G., H. Slor, K. Pfeifer, P. Huhn, A. Bek, S. Orsulic, H. Ushijima, and H. C. Schröder. 1992. Association of AUUUA-binding protein with A + U-rich mRNA during nuclco-cytoplasmic transport. J. Mol. Biol. 226:721-733.
28. Myer, V. E., S. I. Lee, and J. A. Steitz. 1992. Viral small nuclear ribonucleoproteins bind a protein implicated in messenger RNA destabilization. Proc. Natl. Acad. Sci. USA 89:1296-1300.
29. Nakagawa, J., H. Waldner, S. Meyer-Monard, J. Hofsteenge, P. Jenö, and C. Moroni. 1995. AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc. Natl. Acad. Sci. USA 92:2051-2055.
30. Port, J. D., L. Y. Huang, and C. C. Malbon. 1992. β-Adrenergic agonists that down-regulate receptor mRNA up-rcgulate a Mr 35,000 protein(s) that selectively binds to β-adrenergic receptor mRNAs. J. Biol. Chem. 267: 24103-24108.
31. Rajagopalan, L. E., and J. S. Malter. 1994. Modulation of granulocytemacrophage colony-stimulating factor mRNA stability in vitro by the adenosine-uridine binding factor. J. Biol. Chem. 269:23882-23888.
32. Roehl, H. H., and B. L. Semler. 1994. In vitro biochemical methods for investigating RNA-protein interactions in picornaviruscs. Methods Mol. Genet. 4:169-182.
33. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:423-450.
34. Schwartz, S., M. Campbell, G. Nasioulas, J. Harrison, B. K. Felber, and G. N. Pavlakis. 1992. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66:7176-7182.
35. Seedorf, K., G. Krämer, M. Durst, S. Suhai, and W. G. Röwekamp. 1985 Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
36. Stephens, J. M., B. Z. Carter, P. H. Pekala, and J. S. Malter. 1992. Tumor necrosis factor alpha-induced glucose transporter (GLUT-1) mRNA stabilization in 3T3-L1 preadipocytcs. J. Biol. Chem. 267:8336-8341.
37. Tan, W., B. K. Felber, A. S. Zololukhin, G. N. Pavlakis, and S. Schwartz. 1995. Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type I. J. Virol. 69:5607-5620.
38. Tan, W., and S. Schwartz. 1995. The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3′untranslated region. J. Virol. 69: 2932-2945.
39. Turek, L. P. 1994. The structure, function and regulation of papillomaviral genes in infection and cervical cancer. Adv. Virus Res. 44:305-356.
40. Vakalopoulou, E., J. Schaack, and T. Shenk. 1991. A 32-kilodalton protein binds to AU-rich domains in the 3′ untranslated regions of rapidly degraded mRNAs. Mol. Cell. Biol. 11:3355-3364.
41. Wahle, E. 1992. The end of the message: 3′end processing leading to polyadenylated messenger RNA. Biocssays 14:113-118.
42. You, Y., C.-Y. A. Chen, and A.-B. Shyu. 1992. U-rich sequence-binding proteins (URBPs) interacting with a 20-nucleotide U-rich sequence in the 3′ untranslated region of c-fos mRNA may be involved in the first step of c-fos mRNA degradation. Mol. Cell. Biol. 12:2931-2940.
43. Zhang, W., B. J. Wagner, K. Ehrenman, A. W. Schaefer, C. T. DeMaria, D. Crater, K. DeHaven, L. Long, and G. Brewer. 1993. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13:7652-7665.